Clinical Trial Update: XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating first-line Capecitabine/Cisplatin (XP) and S-1/Cisplatin (SP) regimens for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Epidemiological and Clinical Research Information Network | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN